{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:54:34Z","timestamp":1783652074650,"version":"3.55.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":285,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020638","name":"Allergan Aesthetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020638","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019211","name":"AbbVie Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019211","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dr Timothy Ryder from Biological Communications Limited"},{"DOI":"10.13039\/100020638","name":"Allergan Aesthetics, an AbbVie Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020638","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patient satisfaction following cosmetic neurotoxin treatment has been widely studied, but little is known about how this affects downstream behavior.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate the actions taken by patients following cosmetic neurotoxin injection, with regard to their most and least positive treatment experiences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was an online, self-administered survey conducted among adults residing in Brazil, Canada, United Kingdom, and United States. Eligible participants had received 4 or more previous neurotoxin treatments to temporarily improve the appearance of upper facial lines, at least one of which was in the past 12\u2005months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1612 respondents completed the questionnaire (61% female; mean age: 38.1 \u00b1 9.6\u2005years). After their most positive experience, 81% said they engaged in actions directed toward their healthcare professional (HCP) (eg, scheduled another treatment or posted a review on the HCP's website), and 81% took actions directed at others (eg, talked to friends and family or posted a review online). After their least positive experience, 58% engaged in actions directed toward their HCP (with 22% expressing dissatisfaction directly), and 73% took actions to inform other people; many said they discouraged others from using their HCP (52%) or from seeking cosmetic neurotoxin injections altogether (27%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Respondents were less likely to inform their HCP of their satisfaction level after their least positive experience of cosmetic neurotoxin treatment compared with the most positive. Thus, practitioners may often be unaware of dissatisfied individuals. Patient-centered care and consistent proactive follow-up are essential to understanding patient perspectives on outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence<\/jats:title>\n                    <jats:p>5 (Therapeutic)<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/asjof\/ojaf109","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:14:47Z","timestamp":1760012087000},"source":"Crossref","is-referenced-by-count":1,"title":["The Patient Voice in Aesthetic Medicine: Findings From a Global Survey of Cosmetic Neurotoxin Patients"],"prefix":"10.1093","volume":"7","author":[{"given":"Julia K","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Elizabeth","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia","family":"Lipko-Godlewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrence C","family":"Keaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L","family":"Hogue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"2025102911213281800_ojaf109-B1","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1097\/DSS.0000000000002304","article-title":"The unhappy cosmetic patient: lessons from unfavorable online reviews of minimally and noninvasive cosmetic procedures","volume":"46","author":"Watchmaker","year":"2020","journal-title":"Dermatol Surg"},{"key":"2025102911213281800_ojaf109-B2","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1108\/IJOPM-11-2016-0669","article-title":"Healthcare service failure: how dissatisfied patients respond to poor service quality","volume":"38","author":"Um","year":"2018","journal-title":"Int J Oper Prod Manag"},{"key":"2025102911213281800_ojaf109-B3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/jocd.12117","article-title":"The impact of upper facial lines and psychological impact of crow's feet lines: content validation of the Facial Line Outcomes (FLO-11) Questionnaire","volume":"13","author":"Yaworsky","year":"2014","journal-title":"J Cosmet Dermatol"},{"key":"2025102911213281800_ojaf109-B4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/jocd.12166","article-title":"Development and validation of a novel patient-reported treatment satisfaction measure for hyperfunctional facial lines: facial line satisfaction questionnaire","volume":"14","author":"Pompilus","year":"2015","journal-title":"J Cosmet Dermatol"},{"key":"2025102911213281800_ojaf109-B5","doi-asserted-by":"publisher","first-page":"ojz015","DOI":"10.1093\/asjof\/ojz015","article-title":"The psychological impacts of upper facial lines: a qualitative, patient-centered study","volume":"1","author":"Dayan","year":"2019","journal-title":"Aesthet Surg J Open Forum"},{"key":"2025102911213281800_ojaf109-B6","author":"FACE-Q Aesthetics"},{"key":"2025102911213281800_ojaf109-B7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.lrp.2012.09.010","article-title":"Rethinking partial least squares path modeling: in praise of simple methods","volume":"45","author":"Rigdon","year":"2012","journal-title":"Long Range Plann"},{"key":"2025102911213281800_ojaf109-B8","doi-asserted-by":"publisher","first-page":"e000489","DOI":"10.1136\/bmjopen-2011-000489","article-title":"The tip of an iceberg? A cross-sectional study of the general public's experiences of reporting healthcare complaints in Stockholm, Sweden","volume":"2","author":"Wessel","year":"2012","journal-title":"BMJ Open"},{"key":"2025102911213281800_ojaf109-B9","doi-asserted-by":"publisher","first-page":"ojac043","DOI":"10.1093\/asjof\/ojac043","article-title":"The importance of patient mindset: cosmetic injectable patient experience exploratory study\u2014part 1","volume":"4","author":"McDonald","year":"2022","journal-title":"Aesthet Surg J Open Forum"},{"key":"2025102911213281800_ojaf109-B10","doi-asserted-by":"publisher","first-page":"ojac044","DOI":"10.1093\/asjof\/ojac044","article-title":"The importance of functional quality in patient satisfaction: cosmetic injectable patient experience exploratory study\u2014part 2","volume":"4","author":"McDonald","year":"2022","journal-title":"Aesthet Surg J Open Forum"},{"key":"2025102911213281800_ojaf109-B11","doi-asserted-by":"publisher","first-page":"ojac082","DOI":"10.1093\/asjof\/ojac082","article-title":"Factors influencing trust and trustworthiness: cosmetic injectable patient experience exploratory study (CIPEES)\u2014part 3","volume":"4","author":"McDonald","year":"2022","journal-title":"Aesthet Surg J Open Forum"},{"key":"2025102911213281800_ojaf109-B12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11606-018-4540-5","article-title":"Eliciting the patient's agenda- secondary analysis of recorded clinical encounters","volume":"34","author":"Singh Ospina","year":"2019","journal-title":"J Gen Intern Med"},{"key":"2025102911213281800_ojaf109-B13","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1136\/bmj.325.7366.682","article-title":"Spontaneous talking time at start of consultation in outpatient clinic: cohort study","volume":"325","author":"Langewitz","year":"2002","journal-title":"BMJ"},{"key":"2025102911213281800_ojaf109-B14","doi-asserted-by":"publisher","first-page":"e2781","DOI":"10.1097\/GOX.0000000000002781","article-title":"Bifurcation of patient reviews: an analysis of trends in online ratings","volume":"8","author":"Devgan","year":"2020","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"2025102911213281800_ojaf109-B15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1089\/fpsam.2020.0049","article-title":"Online ratings of facial plastic surgeons: worthwhile additions to conventional patient experience surveys","volume":"23","author":"Bovenzi","year":"2021","journal-title":"Facial Plast Surg Aesthet Med"},{"key":"2025102911213281800_ojaf109-B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13010-024-00151-1","article-title":"The ethical foundations of patient-centered care in aesthetic medicine","volume":"19","author":"Buttura da Prato","year":"2024","journal-title":"Philos Ethics Humanit Med"},{"key":"2025102911213281800_ojaf109-B17","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1097\/DSS.0000000000003585","article-title":"High patient satisfaction for up to 6 months with onabotulinumtoxinA treatment for upper facial lines","volume":"48","author":"Cohen","year":"2022","journal-title":"Dermatol Surg"}],"container-title":["Aesthetic Surgery Journal Open Forum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/asjopenforum\/advance-article-pdf\/doi\/10.1093\/asjof\/ojaf109\/64655837\/ojaf109.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/asjopenforum\/article-pdf\/doi\/10.1093\/asjof\/ojaf109\/64655837\/ojaf109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/asjopenforum\/article-pdf\/doi\/10.1093\/asjof\/ojaf109\/64655837\/ojaf109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:21:43Z","timestamp":1761751303000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/asjopenforum\/article\/doi\/10.1093\/asjof\/ojaf109\/8284747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":17,"URL":"https:\/\/doi.org\/10.1093\/asjof\/ojaf109","relation":{},"ISSN":["2631-4797"],"issn-type":[{"value":"2631-4797","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"ojaf109"}}